logo
Pyoderma Gangrenosum in Pregnancy Often Misdiagnosed

Pyoderma Gangrenosum in Pregnancy Often Misdiagnosed

Medscape11-07-2025
TOPLINE:
A systematic review of 63 cases found that pyoderma gangrenosum (PG) during pregnancy or postpartum was often misdiagnosed, delaying treatment and leading to inappropriate interventions.
METHODOLOGY:
Researchers conducted a systematic review of 62 studies describing 63 patients (average age, 29.9 years) with PG during pregnancy or up to 6 weeks postpartum through September 2023.
Of all patients, 27% of patients had a history of PG or PG-like symptoms, 7.9% had a history of inflammatory bowel disease, and 4.8% had another systemic rheumatologic disease. In 71.4% of cases, preceding trauma to the skin was reported.
Outcomes included the misdiagnosis rate, treatment, and maternal and fetal complications.
TAKEAWAY:
During pregnancy, 15.9%, 11.1%, and 7.9% of cases appeared in the first, second, and third trimesters, respectively, while 65.1% were postpartum — primarily at the site of cesarean section scars (55.6%).
Of the 47 cases where an initial diagnosis was reported, only 2 cases were recognized as PG; 45 (95.7%) were initially misdiagnosed as bacterial infections, necrotizing fasciitis, or another skin disorder. Among the 26 cases with data on time to diagnosis, the diagnosis was delayed by more than 7 days in 77%.
Before the diagnosis of PG, surgical wound intervention and broad-spectrum antibiotics were the most frequent treatments, whereas systemic corticosteroids (88.9%) and cyclosporine (33.3%) were most commonly used after PG was diagnosed. All patients showed improvement after treatment, and treatment-related adverse effects were uncommon.
Cesarean section was performed in 40 cases, and 22 of 41 cases with gestational age data were preterm, and there was one case of intrauterine fetal demise.
IN PRACTICE:
These results highlighted 'the frequent misdiagnosis of PG in this population, leading to treatment delays and inappropriate interventions that worsen the condition,' the authors of the study wrote. The study, 'supported by immunological research,' suggested that pregnancy 'may independently contribute to the development of PG,' they added, noting that further research on safe and effective treatment protocols is needed.
SOURCE:
This study was led by Gretchen D. Ball, and Sarah Romanelli, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York City, and was published online on June 30 in the Journal of Drugs in Dermatology.
LIMITATIONS:
This study was limited by its small sample size and inconsistencies in data reporting across case reports. Collecting comprehensive pregnancy outcomes data was challenging due to limited pregnancy details provided in dermatology journals.
DISCLOSURES:
This study was supported by the International Dermatology Outcome Measures nonprofit group. One author disclosed receiving grants and honoraria, and holding stocks in various organizations, including Amgen, AnaptysBio, Avotres Therapeutics, Eli Lilly and Company, Novartis, Sanofi, and XBiotech.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New study reaches landmark conclusion about impact of wind turbines on human health: 'Not a cause-and-effect relationship'
New study reaches landmark conclusion about impact of wind turbines on human health: 'Not a cause-and-effect relationship'

Yahoo

timean hour ago

  • Yahoo

New study reaches landmark conclusion about impact of wind turbines on human health: 'Not a cause-and-effect relationship'

New study reaches landmark conclusion about impact of wind turbines on human health: 'Not a cause-and-effect relationship' A new peer-reviewed study from researchers at Poland's Adam Mickiewicz University has found no evidence that wind turbine noise causes mental harm, putting to rest a persistent and unsubstantiated claim that clean energy projects may be harming our health. Medical Xpress reported that the study measured brainwave activity in 45 university students exposed to different sounds — including traffic, wind turbines, and silence — without revealing the sources. Participants described the turbine noise as white noise and did not report it as any more stressful than city traffic. The researchers also found no measurable differences in brain activity, nor any signs of psychological harm, across the various sound environments. "Although these results cannot be generalized, they support the concept that the interlinkage between exposure to wind turbine noise and human cognitive functioning is not a cause-and-effect relationship," the authors wrote in the study, published in the journal Humanities and Social Sciences Communications. While they acknowledged that their research is not definitive on long-term exposure, they concluded that "wind turbine syndrome" — the conspiracy theory suggesting these sounds cause cancer or mental illness — has no scientific basis. This is reassuring news for consumers and communities. Wind turbines are among the most cost-effective sources of clean energy and can offer great economic and health benefits. They reduce dependence on dirty energy sources like oil and gas, helping to curb rising health risks tied to air pollution. They can also help stabilize public energy grids and lower utility costs for homeowners. Plus, by reducing the amount of heat-trapping air pollution the energy industry generates, we're working toward a safer, cleaner future for all of us. Studies like this help cut through misinformation that could dampen public reception to clean power sources. "This interpretation is compatible with previous findings showing social contexts, such as socialization and misinformation, as a moderator of the interlinkage between wind turbine noise and human functioning," the study authors wrote. A discussion on Reddit shared similar viewpoints on the topic. "Colleague of mine [used] to do community engagement," one commenter said. "Received lots of calls about how the wind turbines were making people in the area sick. She had to tell them that the newly built turbines hadn't actually been switched on yet. Not saying some people weren't having a reaction though as the mind can be a powerful tool (look up the Nocebo effect)." Do you worry about air pollution in your town? All the time Often Only sometimes Never Click your choice to see results and speak your mind. Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the planet. Solve the daily Crossword

Home BP Readings Often Beat Office Measurements
Home BP Readings Often Beat Office Measurements

Medscape

timean hour ago

  • Medscape

Home BP Readings Often Beat Office Measurements

This transcript has been edited for clarity. Do you trust home blood pressure monitoring? You should, especially if it's done correctly. In fact, for many patients, it gives better data than occasional in-office readings, especially if they have white coat hypertension or masked hypertension. Here's how I interpret these data. First, I always ask if the device is validated and used properly. Upper arm cuffs are preferred, not wrist cuffs. Make sure they're sitting quietly for 5 minutes, back is supported, feet are flat, and no caffeine, smoking, or exercise within 30 minutes of the measurement. Then I look at the pattern, not one-off values. I ask patients to check twice in the morning and twice in the evening for 5 or 7 days. That gives me about 20-28 readings, which is enough to assess the true averages. I'm aiming for a home blood pressure goal that is slightly lower than the threshold used in the office, per the guidelines. If the average is above that consistently and the technique is solid, then I consider adjusting the therapy for that particular patient. Also, don't ignore variability. Wide swings may suggest nonadherence, autonomic dysfunction, or even secondary hypertension. If numbers are too low, especially with symptoms, it may be time to reduce the medications. Bottom line, home blood pressure data are reliable when done right. It often gives us a more accurate picture of real-world control than those seen in the office, and it should be part of routine hypertension management.

Mindfulness Therapy Aids IBD Patients With Mental Distress
Mindfulness Therapy Aids IBD Patients With Mental Distress

Medscape

time3 hours ago

  • Medscape

Mindfulness Therapy Aids IBD Patients With Mental Distress

TOPLINE: Mindfulness-based cognitive therapy reduced psychological distress and improved well-being of patients with inflammatory bowel disease (IBD), and it may offer benefits for sleep quality and inflammation. METHODOLOGY: Even in remission, many patients with IBD experience anxiety, depression, fatigue, and poor sleep, which can lower their quality of life, undermine self-care, and drive up healthcare use. Researchers conducted this trial in the Netherlands between July 2021 and May 2022 to strengthen the evidence for the effectiveness of mindfulness-based cognitive therapy in reducing psychological distress in patients with IBD who had been in remission for at least 3 months and experienced at least mild levels of distress. They randomly assigned 142 patients (mean age, 48.6 years; 64.1% women) to receive either mindfulness therapy plus usual treatment (n = 70; intervention group) or only usual treatment (n = 72; control group); the follow-up period lasted 12 months. The mindfulness therapy program included eight weekly group sessions of 2.5 hours, 30-45 minutes of daily home practice, and a 6-hour silent retreat day between sessions six and seven. Usual treatment included pharmacologic and surgical disease control treatments and the prevention of complications. The primary outcome was psychological distress post-intervention (3 months from baseline), measured using the Hospital Anxiety and Depression Scale (HADS) total score. Secondary outcomes included well-being, sleep, self-compassion, mindfulness skills, and disease activity. TAKEAWAY: Patients in the intervention group vs the control group showed reduced psychological distress (Cohen d [d], -0.61) and an improvement in the HADS total score (unstandardized coefficient B, -3.4; P < .001) at 3 months from baseline. The HADS total scores remained lower in the intervention group vs the control group during the entire 12-month follow-up duration. Compared with patients in the control group, those in the intervention group showed improved well-being (d, 0.41) and increases in mindfulness skills (d, 0.46) and self-compassion (d, 0.42). Patients in the intervention group vs the control group had a reduced total sleep time (d, -0.67) but an increased proportion of deep sleep (d, 0.7). No between-group difference was observed in the occurrence of disease flares, but patients in the control group showed a significant reduction in fecal calprotectin levels, an indicator of intestinal inflammation compared with patients in the control group (d, -0.49). IN PRACTICE: 'Our results demonstrate that MBCT [mindfulness-based cognitive therapy] could be a valuable addition to the currently limited number of psychological treatment options for patients with IBD with psychological distress. The group format of MBCT allows for the simultaneous treatment of more patients, potentially making it more cost-effective than individual therapy. Additionally, group therapy provides opportunities for peer support,' the authors of the study wrote. SOURCE: This study, led by Milou M. ter Avest, MD, Department of Psychiatry, Centre for Mindfulness, Radboud University Medical Centre, Nijmegen, the Netherlands, was published online in Inflammatory Bowel Diseases. LIMITATIONS: This study was limited by its unblinded design, risking expectation bias in self-reports. Mindfulness teachers had varied competence levels, which may have introduced bias. The study did not assess sleep disorders such as obstructive sleep apnea, narcolepsy, or restless legs syndrome that may have affected the sleep metrics. Additionally, electroencephalography headbands were not available for all patients, and technical and self-application issues may have led to unusable nights and data loss. DISCLOSURES: This trial was supported by ZonMw (the Netherlands Organisation for Health Research and Development) and the MindMore Foundation. Two authors reported serving on the advisory boards of various pharmaceutical companies, and one of them also reported receiving a grant from Royal DSM. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store